Escola São Paulo de Ciência Avançada em Vacinas
A Escola visa proporcionar aos participantes uma visão crítica e abrangente do estado da arte na pesquisa de vacinas, começando com temas básicos, como "impacto global da vacinação" e aprofundando a temas mais complexos, como "vacinologia de sistemas". Em geral, o programa científico abordará os seguintes temas: importância e impacto das vacinas na saúde pública, imunidade inata e adaptativa, adjuvantes, vacinas convencionais e novas estratégias de vacinação, sistemas de fornecimento de antígenos, testes clínicos/clínicos e vacinologia de sistemas.
O programa de palestras ministradas por pesquisadores internacionalmente renomados inclui temas de pesquisa para o desenvolvimento de vacinas contra patógenos de grande importância, como os que causam malária, AIDS, dengue, Zika e Chikungunya.
Os organizadores propõem a seleção de 80 estudantes, 40 dos quais devem ser preenchidos por candidatos de fora do Brasil. Os alunos selecionados terão a oportunidade de apresentar os resultados de sua pesquisa em sessões de pôsteres e palestras por 10 minutos. Haverá benefícios para hospedar os alunos selecionados provenientes do exterior e de outras cidades do Brasil fora da cidade que hospeda o evento.
A Escola será realizada no Mendes Plaza Hotel, em Santos.
Faculdade de Ciências Farmacêuticas - USP
Área de conhecimento
Irene da Silva Soares
Nº do Processo FAPESP
22/11/2018 a 02/12/2018
Vacinas, Imunologia, Saúde
Chief Scientist & Head of External Research and Development (R&D) at GlaxoSmithKline (GSK) Vaccines. He is known globally for his work in vaccines and immunology. He co-founded the field of cellular microbiology, a discipline combining cell biology and microbiology, and pioneered the genomic approach to vaccine development known as reverse vaccinology.
Dr. Tsuboi has a Doctor of Medicine degree from the School of Medicine at the Ehime University where in 1986 he obtained a Ph.D. in parasitology. In 1997 he became Associate Professor at the Department of Parasitology of the Ehime University, and in 2003 he became Professor at the Cell-free Science and Technology Research Center at the same university. Since 2013 he is a Professor at the Division of Malaria Research and is the Director of the Proteo-Science Center, Ehime University, Japan. His laboratory uses cell-free protein expression technology to study malarial antigens.
Professor at La Jolla Institute for Allergy and Immunology and Co-Director of San Diego Center for Precision Immunotherapy. He is a translational cellular immunologist working on precision cancer immunotherapy through the development of personalized vaccines and cellular therapies.
Dr. Victora obtained Bachelor and Master of Music degrees from the Mannes College of Music. In 2006 he obtained a Master of Science in immunology at the University of Sao Paulo and in 2011 a Ph.D. in immunology at the New York University. He was a Whitehead Fellow at the Whitehead Institute for Biomedical Research from 2012 to 2016. Since 2016 he is an Assistant Professor at the Rockefeller University and head of the Laboratory of Lymphocyte Dynamics. In 2017 he was awarded the MacArthur Genius Grant. His laboratory studies how antibodies are formed.
Dr. Arturo Reyes-Sandoval is an Associate Professor at the Nuffield Department of Medicine (University of Oxford) since 2015. His laboratory has been working on the vaccine development for neglected and emerging infectious diseases, such as Chagas disease, Dengue, Malaria (P. vivax), Zika and Chikungunya. For the last 3 cited diseases, vaccine formulations developed by his group have already entered in the clinical stage testing. Also, he contributed to the creation of the NDM-Mexico initiative to support collaborative work between research groups in Oxford with Mexican scientists.
Prof Nigel Curtis is a clinician scientist who trained in the UK and Canada. He is now based in Australia where he is Head of Infectious Diseases at the Royal Children’s Hospital Melbourne and Professor of Paediatric Infectious Diseases at the University of Melbourne. He is also Leader of the Infectious Diseases & Microbiology Research Group at the Murdoch Children’s Research Institute. His research interests focus on the innate and cellular immune response to BCG vaccine, as well as the immunodiagnosis of childhood TB (or not TB). Prof Curtis leads a large randomised controlled trial of neonatal BCG vaccination to investigate the immunomodulatory heterologous ('non-specific') effects of this vaccine, including its ability to prevent infections, allergic disease and asthma.
Andrew Simpson earned his Ph.D. in 1980 at the National Institute for Medical Research (Mill HillLondon), in the Division of Parasitology and subsequently spent two years at the National Institutes of Health (USA). In 1990, Dr. Simpson moved to Brazil where he continued his research into schistosomiasis and other parasitic diseases while working at the Centro de Pesquisas René Rachou of the Fundação Oswaldo Cruz in Belo Horizonte. In 1995, he joined the Ludwig Institute for Cancer Research (LICR) in São Paulo where he extended his research interests into genomics, and led the FAPESP and national genome projects between 1997 and 2002. In 2002, Dr Simpson transferred to the Ludwig Institute’s office in New York and eventually became LICR Scientific Director in 2007. In 2012, Dr. Simpson left LICR and moved back to Brazil to take up the position of Scientific Director of the Brazilian startup biotechnology company Orygen. Orygen is currently being structured to develop, produce and commercialize therapeutic monoclonal antibodies and vaccines.
Denise da Fonseca
Dr. Fonseca has a Ph.D. in immunology in 2006 from the University of Sao Paulo. From 2012 to 2016 she was a postdoctoral fellow at the Laboratory of Parasitic Diseases of the National Institute of Health. Since 2016 she is a FAPESP Young Researcher at the Department of Immunology of the Institute of Biomedical Sciences, University of Sao Paulo. In 2016 she was awarded the prize L’Oréal-UNESCO For Women in Science. Her laboratory studies the interactions of mucosal immunity and the gut microbiota.
Dr. Larocca joined Dr. Dan Barouch’s laboratory at the Center for Virology and Vaccine Research (Beth Israel Deaconess Medical Center - Harvard Medical School). Currently, he is an Instructor there and his projects aim to develop potential vaccine candidates to prevent viral infections, such as HIV and Zika. His research interests are focused on cellular and humoral immune response as well as in vaccines, viral vectors for vaccination (adenovirus), immunomodulatory pathways, innate immunity and T and B lymphocytes.
Dr. Kallás graduated in Medicine in 1989. In 1996, he obtained a Master’s degree, and in 1999, a Ph.D. in Infectology from the Federal University of São Paulo. Since 2009, he is an Associate Professor at the University of São Paulo School of Medicine. He is also a Researcher at the Laboratory of Clinical Immunology and Allergy (LIM-60), where he carries out translational medicine projects, bringing basic science concepts to clinical applications, especially in infectious diseases.
Dr. Cunha Neto completed his post-doctorate/visiting research internships at the Universities of Stanford (1991) and Harvard (2002), and at the Instituto Roche Milano Ricerche in Italy (1996). In 2001, he became an Associate Professor at the University of São Paulo School of Medicine. He is currently chief of the Laboratory of Clinical Immunology and Allergy (LIM-60) and vice-coordinator of the Research Support Center of the Institute of Immunology Research (INCTiii). His laboratory focuses on translational research in the areas of cellular and molecular immunology of human diseases, with emphasis on the immunopathology of chronic Chagas' heart disease and HIV-1 infection.
Daniela Santoro Rosa
Dr. Rosa obtained her Ph.D. in Microbiology, Immunology and Parasitology from the Federal University of São Paulo in 2006. Since 2010, she is a Professor at the Department of Microbiology, Immunology and Parasitology of the Federal University of São Paulo. Her laboratory is interested in the development and evaluation of new vaccine candidates for HIV, Zika and Chikungunya, and also studies the effect of sleep deprivation on immunity.
Luís Carlos Ferreira
Dr. Ferreira is the current Director of the Biomedical Sciences Institute at University of São Paulo. As head of the Vaccine Development Laboratory, his research interests focus on the development of different vaccine strategies for dengue, dental caries, tumors induced by papilloma virus and diarrhea diseases caused by enteric bacteria.
Dr. Gustavo P. Amarante-Mendes is the current vice-director of the Institute of Biomedical Sciences at the University of São Paulo and was the president of the Brazilian Society of Immunology (2016-2017). He worked as a Research Associate at the La Jolla Institute for Allergy and Immunology, and as visiting scientist at Trinity College Dublin and at Genentech. His laboratory studies cancer immunology and cell-death.
Dr. Bruna-Romero obtained his PhD degree at the University of Navarra, Spain. He completed post-doctoral internships in Spain (ISCIII - Ministry of Health) in 1998 and USA (New York University) in 2001. He was a Visitant Researcher at FIOCRUZ, Brazil from 2001 to 2004, when joined Federal University of Minas Gerais, Brazil as an Assistant Professor. Currently, he is an Associate Professor at the Federal University of Santa Catarina with research interests focused on Immunology and Microbiology towards the development of recombinant vaccines (viral vectors) against infectious diseases.
Dr. Teixeira is Full Professor at the Federal University of Minas Gerais, member of the Brazillian INCT (CNPq) for Vaccine development, Coordenator of the Center of Vaccine Technology in Vaccines, Brazil and has been ranked as 1B Researcher at CNPq, Brazil. Her research interests focus on Molecular Parasitology and Parasite Genomics to evaluate gene expression, parasite-host interactions, genetic variability and DNA repair in Trypanosoma cruzi.
Dr. Bellio has a PhD degree in Biophysics at the Federal University of Rio de Janeiro, Brazil. She is Associate Professor and Head of Department of Immunology at the Federal University of Rio de Janeiro. Her research interests focus on Cellular Immunology aspects, such as antigen recognition by TCR, role of TLRs in the cytotoxic CD8+ T cell response against Trypanosomatides, MyD88-dependent signalling pathways in Th1 response, development of vaccines based on recombinant phages as vaccine vectors, B cell maturation, homeostasis of Treg cells and control mechanism for experimental colitis and ZIKV-specific immunity.
Ana Paula Fernandes
Dr. Fernandes has a PhD degree in Parasitology at the Federal University of Minas Gerais, Brazil in 1997. Currently, she is Full Professor at the Federal University of Minas Gerais and has been ranked as 1B Researcher at CNPq, Brazil. Her research interests focus on the development of diagnostics, molecular epidemiology, vaccine and treatment against infectious diseases as Leishmaniasis. Also, risk factors associated with hipercoagulation states have been investigated.
Dr Pedro Fernando da Costa Vasconcelos is the Director of the Instituto Evandro Chagas (IEC), in Para, Brazil. Experience in Microbiology, Tropical Medicine and Pathology, with emphasis on Virology, working on the following topics: dengue, yellow fever, hantavirus, rabies, as well as in epidemiology, molecular biology of viruses, pathogenesis, and description and characterization of new arboviruses, and neurosciences especially neuroinfections caused by arboviruses. More than 250 articles and 60 book chapters published in journals and scientific books in Brazil and abroad.
Dr. Zamboni is an Associate Professor at the Ribeirão Preto School of Medicine, University of São Paulo (FMRP/USP) and an Affiliate Member of TWAS (The World Academy of Sciences - TWAS/UNESCO). The research carried out by Dr. Zamboni involves areas of Cell Biology, Microbiology and Immunology, with special emphasis on Pathogen-Host Cell Interaction and aspects of Microbial Pathogenesis and Innate Immunity.
Fabio Trindade Costa
Dr. Costa is an Associate Professor at the State University of Campinas (UNICAMP) where he is also coordinator of international actions of the Institute of Biology and the postgraduate program in Genetics and Molecular Biology. He served as UNICAMP's international relations adviser from 2010 to 2012. His lines of research involve immunopathological aspects of malaria and the development of new drugs and experimental vaccines.
Dr. Bortoluci holds a Ph.D. (2003) and post-doc (2005) in Immunology from the University of São Paulo. She is currently an Associate Professor in the Department of Biological Sciences at the Federal University of São Paulo (UNIFESP), and responsible for the Molecular Immunology Laboratory in the Center for Cellular and Molecular Therapy (CTC-Mol). The main focus of her research group is the study of the molecular pathways involved in the activation of inflamomasomes and their impact on the control of infections caused by Salmonella typhimurium, Trypanosoma cruzi and Zika virus.
Ricardo Palácios Gomez
Dr. Palácios Gomez is is currently Research and Clinical Development Manager of the Butantan Institute. He holds a medical degree from the National University of Colombia (1995) and a social sciences degree from the University of São Paulo (2016). He has also a PhD in Infectology from the Federal University of São Paulo (2006) and a specialization in Bioethics from the University of São Paulo (2012).
José Ronnie de Vasconcelos
Dr. Carvalho de Vasconcelos has a PhD in Microbiology and Immunology from the Federal University of São Paulo (2004). He is currently Adjunct Professor in the Department of Biosciences of the Federal University of São Paulo (Campus Baixada Santista). His research lines focus on the development of DNA and recombinant adenovirus vaccines against Trypanosoma cruzi, the causative agent of Chagas Disease.
Estudo pode revelar como a zika causa lesões no cérebro
Agência FAPESP - 29/11/2018
Escola São Paulo de Ciência Avançada em Vacinas
Agência FAPESP - 16/05/2018